Phase 1 clinical trials for psilocybin show no adverse effects
A team of researchers from King’s College London and mental healthcare company Compass Pathways has released the results of a
Read moreA team of researchers from King’s College London and mental healthcare company Compass Pathways has released the results of a
Read more